TY  - GEN
AU  - Wang,Kening
AU  - Tomaras,Georgia D
AU  - Jegaskanda,Sinthujan
AU  - Moody,M Anthony
AU  - Liao,Hua-Xin
AU  - Goodman,Kyle N
AU  - Berman,Phillip W
AU  - Rerks-Ngarm,Supachai
AU  - Pitisuttithum,Punnee
AU  - Nitayapan,Sorachai
AU  - Kaewkungwal,Jaranit
AU  - Haynes,Barton F
AU  - Cohen,Jeffrey I
TI  - Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1
SN  - 1098-5514
PY  - 2017///0926
KW  - AIDS Vaccines
KW  - immunology
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibody-Dependent Cell Cytotoxicity
KW  - Cell Line
KW  - Eye Diseases
KW  - prevention & control
KW  - Female
KW  - HIV Envelope Protein gp120
KW  - genetics
KW  - Herpes Simplex
KW  - Humans
KW  - Killer Cells, Natural
KW  - Leukocytes, Mononuclear
KW  - Lymphocyte Activation
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Receptors, Tumor Necrosis Factor, Member 14
KW  - Simplexvirus
KW  - Viral Envelope Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1128/JVI.00411-17
ER  -